Charts Telix Pharmaceuticals Limited Nasdaq
Stocks
TLX
US87961M1053
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.79 USD | +2.34% |
|
+17.66% | +57.41% |
| 08-06 | ASX Biggest Gainers | MT |
| 07-24 | Telix Says Thyroid Cancer Therapy Candidate Shows Encouraging Disease Control, Acceptable Safety Profile in Real-World Data Review | MT |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- TLX Stock
- TLX Stock
- Charts Telix Pharmaceuticals Limited
Select your edition
All financial news and data tailored to specific country editions
